首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   12171篇
  免费   968篇
  国内免费   568篇
耳鼻咽喉   44篇
儿科学   249篇
妇产科学   65篇
基础医学   496篇
口腔科学   81篇
临床医学   715篇
内科学   784篇
皮肤病学   98篇
神经病学   359篇
特种医学   206篇
外国民族医学   7篇
外科学   633篇
综合类   1273篇
预防医学   1115篇
眼科学   237篇
药学   4562篇
  1篇
中国医学   1200篇
肿瘤学   1582篇
  2023年   153篇
  2022年   214篇
  2021年   280篇
  2020年   382篇
  2019年   404篇
  2018年   394篇
  2017年   482篇
  2016年   510篇
  2015年   420篇
  2014年   672篇
  2013年   1215篇
  2012年   718篇
  2011年   768篇
  2010年   590篇
  2009年   612篇
  2008年   588篇
  2007年   617篇
  2006年   526篇
  2005年   457篇
  2004年   413篇
  2003年   357篇
  2002年   295篇
  2001年   268篇
  2000年   207篇
  1999年   187篇
  1998年   156篇
  1997年   162篇
  1996年   140篇
  1995年   149篇
  1994年   150篇
  1993年   146篇
  1992年   117篇
  1991年   82篇
  1990年   98篇
  1989年   86篇
  1988年   101篇
  1987年   59篇
  1986年   40篇
  1985年   93篇
  1984年   71篇
  1983年   71篇
  1982年   60篇
  1981年   32篇
  1980年   38篇
  1979年   19篇
  1978年   25篇
  1977年   15篇
  1976年   27篇
  1975年   15篇
  1973年   7篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
药物非临床安全性评价毒性试验有害作用的判断非常重要,因其可为保护临床试验暴露于新化学实体或药物的受试者提供重要信息。毒性试验组织病理学检查可提供受试物毒性作用的形态学数据,帮助分析和确定有害作用和非有害作用及其剂量水平。参照美国毒性病理学会(STP)和欧洲毒性病理学会(ESTP)的推荐最佳实践或建议及其他相关文献,对有害作用的定义、区分有害作用与非有害作用的要素、有害作用数据沟通和使用来评估人类潜在风险等建议等进行简要概述分析,以期为我国非临床药物安全性评价毒性试验中有害作用判定提供参考。  相似文献   
2.
3.
4.
In the present study, we aimed to observe the effects of ethanol extract of Oxalis corniculata L. on bleeding time (BT) and coagulation time (CT) and determine its acute toxicity in mice. Firstly, the ethanol extract of O. corniculata was administered to 40 mice, which were randomly divided into the normal control group, Yunnan Baiyao control group, low-dose group, and high-dose group. The low-dose (0.6 g/kg) and high-dose (1.2 g/kg) groups received ethanol extract of O. corniculata by gavage, and the BT and CT of the mice were measured by the slide method and tail clipping method, respectively. Secondly, the median lethal dose method was used with 50 mice to observe the physiological state, poisoning reaction, and death of the mice after intragastric administration. Finally, on the 14th day of the experiment, a necropsy was performed to observe any abnormality of the organs. In conclusion, in the coagulation and hemostasis tests, there were no statistical differences between the groups (P > 0.05), while there was a significant dose-response relationship, and the BT and CT were significantly shorter than those of the negative control group, which were comparable to the Yunnan Baiyao control group. Moreover, in the acute toxicity test, the median lethal dose of ethanol extract of O. corniculata was 6.0291 g/kg, with a 95% confidence interval of 5.3065–6.7829 mg/kg.  相似文献   
5.
6.
7.
IntroductionSelective internal radiation therapy (SIRT) is a potential treatment of primary renal cell carcinoma (RCC) deemed unsuitable for conventional therapy. RESIRT is the first-in-human study to evaluate safety and feasibility of SIRT for primary RCC.Patients and MethodsPatients with RCC, unsuitable for, or who declined conventional therapy, were eligible. A single transfemoral micro-catheter administration of yttrium-90 (Y-90) resin microspheres (SIR-Spheres) was delivered super selectively via the renal artery to the tumour at intended radiation doses of 75, 100, 150, 200, 300 Gy and a final cohort with a procedural endpoint of “imminent stasis,” in a dose-escalation design. Post-SIRT follow-up was 12 months. Study endpoints included safety and toxicity 30-days and 12-months post-SIRT and tumour response (RECIST v1.1).ResultsIn total, 21 patients were enrolled, mean (SD) age was 75 (9.3) years, WHO performance status was 0 in 81%, 12 (57%) had stage 3 chronic kidney disease, and 7 (33%) had prior contralateral nephrectomy. Overall, 71% of patients completed 12 months of follow-up. Intended doses were delivered without any dose-limiting toxicity. Seventeen out of 21 (81%) patients experienced an adverse event (AE) from any cause within 30 days post-SIRT; all SIRT-related AEs were grade 1 to 2. Best overall tumour responses were partial response 1/21 (4.8%), stable disease 19/21 (90.5%) and progressive disease 1/21 (4.8%).ConclusionThis study demonstrated good tolerability of SIRT at all dose levels including “imminent stasis” in treating primary tumours in RCC patients otherwise unsuitable for conventional therapy. SIRT with Y-90 resin microspheres may be a feasible treatment option for RCC.  相似文献   
8.
曾普华 《陕西中医》2021,(8):987-990,1137
炎症被视为肿瘤的第七大生物学特征,而肿瘤被称作“永不愈合的伤口”。炎性微环境作为肿瘤微环境的重要组成部分,不仅诱导正常细胞向肿瘤细胞转化,导致肿瘤的发生,还通过分泌炎性细胞因子、趋化因子参与上皮-间质转化、血管新生、代谢重编程等过程,促进肿瘤侵袭、转移及恶液质的发生。中医学认为,癌毒与痰浊、瘀血、热毒相互滋助、互为因果,胶结留着于至虚之处而发为肿瘤。癌毒窃夺精血、损耗正气,使机体出现“虚劳”之候,体现了肿瘤恶液质 “癌毒致虚” 的病机特点。本文总结分析了炎性微环境在肿瘤恶液质发生发展中的关键作用,并探析其与中医学“癌毒致虚”病机理论的相关性,为“癌毒致虚”治疗肿瘤恶液质提供科学依据。  相似文献   
9.
Abstract

Purpose

Financial hardship can be a major cause of distress among persons with cancer, resulting in chronic stress and impacting physical and emotional health. This paper provides an analysis of the lived experience of cancer patients’ financial hardship from diagnosis to post-treatment.  相似文献   
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号